Advertisement

Topics

Search Results for "Neupro"

02:42 EST 9th December 2016 | BioPortfolio

Matching Channels

None

Matching News

US court rules in favour of UCB in patent dispute, shares jump

UCB has received a major boost after a Delaware district court confirmed the validity of the company’s patents on one of its major drugs, the anti-seizure drug Vimpat (lacosamide). The court decisio...

UCB, Inc. Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryUCB, Inc. UCB, a subsidiary of UCB S.A. is a pharmaceutical company that develops products with an emphasis on central nervous system and immunology therapeutic domains. The company's products ...

UCB S.A. UCB Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryUCB S.A. UCB is a biopharmaceutical company that discovers and develops medicines and solutions to help treat various diseases. It focuses mainly on products for the treatment of central nervou...

NewBridge Pharmaceuticals FZLLC Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryNewBridge Pharmaceuticals FZLLC NewBridge Pharmaceuticals is a pharmaceutical company that offers solutions to biological, genomics, pharmaceuticals, and healthcare companies. The company offer...

Matching PubMed Articles

Clinical Pharmacology and efficacy of rotigotine (Neupro® patch) in the treatment of restless leg syndrome.

Restless legs syndrome/Willis Ekbom disease (RLS/WED) is a sensorimotor disorder characterized by unpleasant sensations in the legs accompanied by an urge to move them, that typically occurs and tend ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement